Start-up to develop new treatment for heart failure
Our Department exploits their academic findings towards rational therapy development for genetic and acquired forms of heart failure in the Dutch spin-off company Mirabilis Therapeutics BV that was founded in 2015.
Mirabilis Therapeutics BV is a drug development company dedicated to the discovery and development of innovative products in the field of cardiovascular diseases.
For more information on Mirabilis Therapeutics BV, please visit: www.mirabilis-therapeutics.com
Also read
-
Regio Deal Noord-Limburg accelerates research into robotics, AI, and autonomous cultivation
With funding from the Regio Deal Noord-Limburg II, Maastricht University is stepping up its ambitions in Venlo. Thanks to this investment, the university can further expand its research into robotics and artificial intelligence for autonomous systems in horticulture.Researchers
-
Responsible use of AI at school starts with parents
It’s a fear shared by many parents and teachers: students who don’t do their schoolwork themselves, but have it done by AI tools such as ChatGPT. The concerns are not unfounded. Nonetheless, education also stands to gain a great deal from the safe and effective use of artificial intelligence.
-
Innovation in action: rapid analysis of bacteria in food and crop health
Real-time analysis of plant health or harmful bacteria during food production is becoming a reality. Thanks to funding from the Province of Limburg and Europe, researchers at the Sensor Engineering research institute start working on both projects.
